Expert Advice: Understanding Pharmacist Recommendations for branded versus Generic Over-the-Counter medication

How to cite

Durodola, Christi-Anna; Vadovic, Radovan; Ammi, Mehdi; Hoffman, Vivian. 2026. "Expert Advice: Understanding Pharmacist Recommendations for branded versus Generic Over-the-Counter medication." AEA RCT Registry. AEARCTR-0019351. https://doi.org/10.1257/rct.19351-1.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Christi-Anna Durodola* , Radovan Vadovic , Mehdi Ammi , Vivian Hoffman

* Primary investigator

Registry ID
AEARCTR-0019351
DOI
https://doi.org/10.1257/rct.19351-1.0
First registered
Last updated
Status
On going
Trial dates
2025-08-31 – 2026-08-31
Countries
Canada (Ontario)
JEL codes
N/a
Secondary IDs
N/a
Registry record
http://www.socialscienceregistry.org/trials/19351

Abstract

This study examines how pharmacists recommend brand-name versus generic over-the-counter pain medications and whether the way a consumer asks for advice affects the recommendation they receive. Although generic medications contain the same active ingredients as their brand-name equivalents and are often less expensive, consumers may still rely on familiar brand names when choosing over-the-counter medications. Pharmacists are well positioned to help consumers make these choices, but relatively little is known about how they communicate this information during everyday interactions.

The study will take place in community pharmacies in Ottawa, Canada. Researchers will visit pharmacies while posing as ordinary consumers seeking advice about an over-the-counter pain medication. Pharmacies will receive two different types of consumer inquiries on separate visits. One inquiry will be open-ended, allowing the pharmacist to make a recommendation without being presented with specific products. In the other, the consumer will explicitly present a choice between a brand-name and generic version of the same medication and ask the pharmacist which they recommend. The order of the two interactions will vary across pharmacies.

We will compare pharmacists’ recommendations across the two types of interactions. We will also examine the explanations pharmacists provide, including whether they discuss differences or similarities in cost, effectiveness, active ingredients, or product equivalence. The study aims to improve our understanding of how expert advice and the way consumers frame questions can influence decisions between branded and generic medications.

Intervention

The study varies how a consumer requests advice from a pharmacist about an over-the-counter pain medication. Participating pharmacy locations are exposed to two standardized consumer inquiry conditions on separate visits. One condition allows the pharmacist to provide an unsolicited product recommendation, while the other makes the choice between alternative versions of the medication more explicit. The order of the two conditions is varied across pharmacy locations. This design allows us to examine whether the framing of a consumer’s request affects the advice provided by pharmacists.

Experimental design

This study uses a naturalistic field experiment in community pharmacies in Ottawa, Canada. Each pharmacy is observed under two different consumer inquiry conditions on separate visits. The order of the conditions varies across pharmacy locations. This paired design allows us to compare how the same pharmacy responds to different ways of framing a request for advice while reducing the influence of stable differences across pharmacy locations. The study focuses on whether consumer framing affects pharmacists’ recommendations between branded and generic over-the-counter pain medications and the information they provide alongside those recommendations.

Design details

Randomization method
Pharmacies were selected from a master list using stratified random selection based on geographic location and pharmacy type. Selected pharmacies were then randomly assigned to receive either the Open-Ended condition or the Brand-versus-Generic condition on the first visit. Each pharmacy receives the alternate condition on the second visit.
Randomization unit
Pharmacy location (site). Randomization was conducted at the pharmacy-site level. The randomized element is the order in which each pharmacy receives the two consumer inquiry conditions.
Clusters
100 pharmacy locations, with two interactions per pharmacy, for a planned total of approximately 200 pharmacist interactions.
Observations
200
Arms
100 BrandvsGeneric 100 Open-ended
Primary outcomes
Pharmacist recommendation of branded versus generic OTC pain medication. The primary outcome is the type of medication recommended by the pharmacist during the interaction, classified as a generic medication/active ingredient, a brand-name product, both/either, or no clear recommendation.
Secondary outcomes
Content and reasoning accompanying the pharmacist’s recommendation. Secondary outcomes include whether the pharmacist mentions brand-generic equivalence, cost, effectiveness, brand familiarity, product availability, the active ingredient/ibuprofen, or product location, as well as any other reasoning offered. We will also examine physical indications of product endorsement and responses to the standardized follow-up question in the Brand-versus-Generic condition.

Cited by

No citation data available for this registration yet.

Keywords